Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole prophylaxis of gastrointestinal bleeding and gastroesophageal reflux in critically ill children
2007-006102-19Phase 4Active
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omeprazole in gastrointestinal bleeding, gastroesophageal reflux disease (GERD) and Acute Stress Gastritis (2 arms), sponsored by Gregorio Marañón University General Hospital. Primary endpoint: Efficacy parameters. Started Jan 2008; status: active.
02
Drugs
omeprazole
03
Conditions
gastrointestinal bleedinggastroesophageal reflux disease (GERD)Acute Stress Gastritis
Beyond the preview
Go deeper on 2007-006102-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006102-19.